CRISPR start-up Graphite Bio launches with $45 million for targeted DNA integration

Wednesday, September 16, 2020 - 16:10 in Biology & Nature

Firm's initial focus is sickle cell disease, based on work by Stanford scientist Matthew Porteus

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net